Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion type Assertion NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_head.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion description "[Both the growth-promoting and receptor-upregulating effects induced by rhIL-6 could be blocked by treating AML-193 cells with neutralizing anti-gp130 antibodies (GPX7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_provenance.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion evidence source_evidence_literature NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_provenance.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion SIO_000772 8641372 NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_provenance.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion wasDerivedFrom befree-20140225 NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_provenance.
- NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_assertion wasGeneratedBy ECO_0000203 NP842528.RA7842ofFil_hLqntityZOP-ATmjXv2-KsJdQ1Eq6XVWk130_provenance.